Atrium Therapeutics (RNA) CSO granted RSUs and 60,000 stock options in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Atrium Therapeutics, Inc. Chief Scientific Officer Husam Younis reported equity compensation awards. He received 30,000 shares of common stock as restricted stock units, which vest 25% on March 20, 2027 and then in three yearly installments, contingent on continued service. He was also granted options for 60,000 shares of common stock at an exercise price of $14.30 per share, vesting 25% on March 20, 2027 and the balance in 36 equal monthly installments through April 20, 2036. Following the stock award, his direct common stock holdings total 52,657 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Younis Husam
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 60,000 | $0.00 | -- |
| Grant/Award | Common Stock | 30,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 60,000 shares (Direct, null);
Common Stock — 52,657 shares (Direct, null)
Footnotes (1)
- Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Twenty-five percent (25%) of the shares underlying this option shall vest and become exercisable on March 20, 2027, with the remaining shares vesting in thirty-six (36) substantially equal monthly installments each month thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
Key Figures
RSU grant: 30,000 shares
Option grant size: 60,000 shares
Option exercise price: $14.30 per share
+4 more
7 metrics
RSU grant
30,000 shares
Restricted stock units awarded to CSO on April 20, 2026
Option grant size
60,000 shares
Stock options for common stock granted on April 20, 2026
Option exercise price
$14.30 per share
Exercise price for 60,000 stock options
Common shares held after grant
52,657 shares
Direct common stock holdings after RSU award
RSU initial vesting date
March 20, 2027
25% of RSUs vest on this date
Option vesting pattern
25% then 36 monthly installments
Vesting schedule after March 20, 2027
Option expiration
April 20, 2036
Expiration date of the stock options
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), vest, exercise price, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of $14.30 per share"
vest financial
"Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"shares underlying this option shall vest and become exercisable with a $14.30 exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
monthly installments financial
"remaining shares vesting in thirty-six (36) substantially equal monthly installments"
Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.
FAQ
What did Atrium Therapeutics (RNA) disclose in this Form 4 for Husam Younis?
Atrium Therapeutics reported that Chief Scientific Officer Husam Younis received equity compensation, including restricted stock units and stock options. These grants increase his direct equity stake and are subject to multi‑year vesting tied to his continued service with the company.
What stock options were granted to Husam Younis by Atrium Therapeutics (RNA)?
He received stock options covering 60,000 shares of Atrium Therapeutics common stock. The options have a $14.30 exercise price, with 25% vesting on March 20, 2027 and the remainder vesting in 36 equal monthly installments, subject to continued service.
When do Husam Younis’s Atrium Therapeutics (RNA) RSUs and options vest?
Both awards start vesting on March 20, 2027. For RSUs, 25% vest then and the rest in three annual installments. For options, 25% vest on that date and the remaining shares vest monthly over 36 months, assuming ongoing employment.
What is the expiration date of Husam Younis’s Atrium Therapeutics (RNA) stock options?
The stock options granted to Husam Younis are scheduled to expire on April 20, 2036. They vest over time starting March 20, 2027, with 25% vesting initially and the remaining portion vesting in 36 equal monthly installments, assuming continuous service.